<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0030">
 <label>6</label>
 <element-citation publication-type="journal" id="h0030">
  <person-group person-group-type="author">
   <name>
    <surname>Du</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>He</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Zheng</surname>
    <given-names>B.-J.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>The spike protein of SARS-CoV â€” a target for vaccine and therapeutic development</article-title>
  <source>Nat Rev Microbiol</source>
  <volume>7</volume>
  <issue>3</issue>
  <year>2009</year>
  <fpage>226</fpage>
  <lpage>236</lpage>
  <comment>Epub 2009 Feb 9. Review. PubMed PMID: 19198616; PubMed Central PMCID: PMC2750777</comment>
  <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/articles/nrmicro2090" id="ir025" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.nature.com/articles/nrmicro2090</ext-link>
  <pub-id pub-id-type="doi">10.1038/nrmicro2090</pub-id>
  <pub-id pub-id-type="pmid">19198616</pub-id>
 </element-citation>
</ref>
